Patents Assigned to Lab 21 Limited
  • Methods and compositions for identifying and characterizing hepatitis C
    Patent number: 8173795
    Abstract: The invention provides novel methods and compositions for amplifying portions of the HCV genome. The nucleic acid sequences set forth as SEQ ID NOS:1-64 derived from HCV cDNA and functional equivalents thereof, kits containing same, and methods employing same, are useful for the identification and characterization of HCV in biological samples.
    Type: Grant
    Filed: July 21, 2008
    Date of Patent: May 8, 2012
    Assignee: Lab 21 Limited
    Inventor: Carol Holland-Staley
  • Methods and Compositions For Identifying and Characterizing Hepatitis C
    Publication number: 20090047663
    Abstract: The invention provides novel methods and compositions for amplifying portions of the HCV genome. The nucleic acid sequences set forth as SEQ ID NOS:1-64 derived from HCV cDNA and functional equivalents thereof, kits containing same, and methods employing same, are useful for the identification and characterization of HCV in biological samples.
    Type: Application
    Filed: July 21, 2008
    Publication date: February 19, 2009
    Applicant: Lab 21 Limited
    Inventor: Carol Holland-Staley